N-(2-chloro-6-(2-fluoroethoxy)pyridin-4-yl)-2-(4-(4-fluorophenyl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide

ID: ALA5204017

Chembl Id: CHEMBL5204017

PubChem CID: 168293778

Max Phase: Preclinical

Molecular Formula: C21H18ClF2N7O2

Molecular Weight: 473.87

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncc2c(-c3ccc(F)cc3)cc(NNC(=O)Nc3cc(Cl)nc(OCCF)c3)nc21

Standard InChI:  InChI=1S/C21H18ClF2N7O2/c1-31-20-16(11-25-31)15(12-2-4-13(24)5-3-12)10-18(28-20)29-30-21(32)26-14-8-17(22)27-19(9-14)33-7-6-23/h2-5,8-11H,6-7H2,1H3,(H,28,29)(H2,26,27,30,32)

Standard InChI Key:  UEDRIYLPOWYDSM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5204017

    ---

Associated Targets(Human)

S1PR2 Tchem Sphingosine 1-phosphate receptor Edg-5 (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW620/5-FU (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 473.87Molecular Weight (Monoisotopic): 473.1179AlogP: 4.32#Rotatable Bonds: 7
Polar Surface Area: 105.99Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.82CX Basic pKa: 1.43CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.90

References

1. Luo D, Guo Z, Zhao X, Wu L, Liu X, Zhang Y, Zhang Y, Deng Z, Qu X, Cui S, Wan S..  (2022)  Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists.,  227  [PMID:34688013] [10.1016/j.ejmech.2021.113923]

Source